Clinical Trial Update: New Dual Therapy for Primary Treatment of Helicobacter Pylori Infection：a Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated a new dual therapy for the primary treatment of Helicobacter pylori infection in patients with functional dyspepsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia
• Helicobacter Pylori Infection

Drugs mentioned

• Undisclosed dual therapy

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Functional Dyspepsia | Phase 2 | Status: COMPLETED